| Code | Description | Claims | Beneficiaries | Total Paid |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
9,604 |
4,013 |
$331K |
| 99233 |
Prolong inpt eval add15 m |
5,034 |
2,518 |
$279K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,910 |
750 |
$235K |
| 99223 |
Prolong inpt eval add15 m |
1,757 |
1,624 |
$193K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,852 |
1,678 |
$80K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
830 |
754 |
$25K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
155 |
132 |
$10K |
| 94729 |
|
342 |
296 |
$9K |
| 94060 |
|
291 |
252 |
$8K |
| 94727 |
|
340 |
294 |
$7K |
| 95811 |
|
28 |
24 |
$3K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
15 |
14 |
$2K |
| 94375 |
|
59 |
56 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
166 |
149 |
$1K |
| 99442 |
|
57 |
55 |
$1K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
27 |
17 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
82 |
60 |
$800.53 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
27 |
13 |
$544.48 |
| 99441 |
|
43 |
41 |
$296.28 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
35 |
28 |
$249.37 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
246 |
220 |
$17.79 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
15 |
15 |
$0.00 |
| G8925 |
Spirometry test results demonstrate fev1 >= 60% fev1/fvc >= 70%, predicted or patient does not have copd symptoms |
14 |
12 |
$0.00 |